Research published today shows how digital providers are coming together to support the mental health needs of millions of users unable to access traditional services during the COVID-19 pandemic. [Read more…] about Survey finds concerns AND hope to address growing mental health needs due to the covid pandemic
Technology & Innovation
Mightier, provider of a ground-breaking video game system for teaching children emotional regulation, today announced the company has been awarded a $2 million grant from the National Institute of Mental Health (NIMH) to support research on the impact of video games on improving children’s mental health. [Read more…] about Can biofeedback-based videogames help children better manage stress? Magellan Health and Mightier secure $2 million NIMH grant to investigate
Addressing the mental health crisis (Pharma Field):
Each day we find out more about the mental health effects of the pandemic. Early on, the Office for National Statistics found that one in five Britons reported symptoms of depression, compared with one in 10 before. And, according to a recent study led by the University of Nottingham and King’s College London, stress, anxiety and depression were all significantly higher in participants compared with ‘population norms’, with 64% of the participants reporting symptoms of depression and 57% reporting symptoms of anxiety. [Read more…] about The landscape of digital mental health apps: huge unmet needs, quality concerns, app stores asked to ensure transparency
Alzheimer’s Prediction May Be Found in Writing Tests (The New York Times):
… the researchers looked at a group of 80 men and women in their 80s — half had Alzheimer’s and the others did not. But, seven and a half years earlier, all had been cognitively normal. [Read more…] about Study: Artificial intelligence program identifies linguistic markers that predict, with 70% accuracy, who gets Alzheimer’s Disease years later
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring a life well lived, the latest news on brain health and innovation, and some brain teasers in honor of International Brain Teaser Month.
#1. Thank you, Sharon. We won’t. “Never stop wondering” — Sharon Begley, science journalist, RIP
#2. Write injuries in sand, kindnesses in ____________.
Milk the cow, but do not pull off the ___________.
Enjoy these 5 US and 7 international proverbs to test your cognitive skills.
#3. Beware the snakes as you tease your mind with this optical illusion.
#4. The blood-brain barrier is hopefully hard at work: Can COVID-19 coronavirus “invade” human brain tissue? (Quick answer: evidence so far is mixed)
#5. Yes, a bit circular…but that’s the point: To manage stress, sleep better. To sleep better, keep a good routine and manage stress.
#6. Excellent article for those interested in state-of-the-art neurotech. The Promise of Big Data Imaging for Mental Health
#7. We’d much rather see the NIH or a fitness or nutrition company sponsor such a promising study, rather than a pharma company, but this is great news anyway: The new frontier in neurocognitive monitoring and dementia screening: the Apple Watch
#8. “I am encouraged by Cognito’s innovative approach,” said Allan Levey, M.D., Ph.D., Professor and Chairman of the Department of Neurology at Emory University and Director of the Emory Goizueta Alzheimer’s Disease Research Center. “This strategy translating recent advances in non-invasive modulation of brain activity with sensory stimulation with light and sound has the potential to be an urgently needed safe, non-invasive, and effective treatment for millions of individuals with Alzheimer’s disease.” Neurostimulation device GammaSense by Cognito Therapeutics secures FDA Breakthrough Device Designation to explore Alzheimer’s Disease applications
#9. This can help a ton of people, given that “Currently, video EEG is the gold standard for seizure detection, but it requires a hospital stay, is often costly, and can be stigmatizing.” Study: Wearable sensors and machine learning may well (one day) help detect a broad range of epileptic seizures
#10. “While 66% accuracy may not sound high, it is an improvement on current accuracy levels of diagnosis by human clinicians, particularly general physicians who aren’t trained in psychiatry.” Machine learning study finds standardized brain scan biomarker to detect depression with 66% accuracy
#11. FDA releases first Artificial Intelligence (AI) regulatory plan to promote responsible digital health innovation. Two of the priorities are the “issuance of draft guidance on a predetermined change control plan (for software’s learning over time)” and “Developing methods to evaluate and improve machine learning algorithms.” Both are crucial given that data-driven innovation is in flux by definition, unlike drug-driven innovation.
#12. The law of averages suggests 2021 will be a good year … Here’s a toast to a Healthy, Happy & Meaningful New Year.
The SharpBrains Team
FDA Releases Artificial Intelligence/Machine Learning Action Plan (FDA press release):
Today, the U.S. Food and Drug Administration released the agency’s first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency’s oversight of AI/ML-based medical software … The AI/ML-Based Software as a Medical Device Action Plan outlines five actions that the FDA intends to take, including:
- Further developing the proposed regulatory framework, including through issuance of draft guidance on a predetermined change control plan (for software’s learning over time);